Meadowhawk Biolabs, Inc. — Form D
Meadowhawk Biolabs, Inc. of MARLBOROUGH, MA, a company, filed a Form D exempt-offering notice with the SEC on 2023-03-17. The offering totals $6.0M, of which $6.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2023-03-17
- Form: D
- Accession: 0001969871-23-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $6.0M
- Amount sold: $6.0M
- Minimum investment: $19K
- Investors: 9
- Date of first sale: 2023-03-03
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-476221
Issuer
- Name: Meadowhawk Biolabs, Inc.
- CIK: 0001969871
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2021
- Address: 33 LOCKE DRIVE, MARLBOROUGH, MA, 01752
- Phone: 617-798-6181
Officers, directors & promoters (8)
| Name | Role | Location |
|---|
| Peter Glick | Director | Marlborough, MA |
| Peter Glick | Executive Officer | Marlborough, MA |
| James Jersey | Director | Marlborough, MA |
| James Jersey | Executive Officer | Marlborough, MA |
| Jessica Sullivan | Executive Officer | Malborough, MA |
| Herbert Hooper | Director | Marlborough, MA |
| Glick Peter | Director | Marlborough, MA |
| Glick Peter | Executive Officer | Marlborough, MA |
Other filings by this issuer (2)
More